Search results
Vaccine Safety and DMT for Highly Active MS: New Data
Medscape· 2 days agoMany clinicians delay CD20 treatment until vaccine schedules are complete. A study suggests that this precaution may not be necessary.
China's drugmakers can't sell mRNA shots but haven't quit yet
Reuters· 6 days agoChina's vaccine developers stuck with unused mRNA COVID shots and idle manufacturing plants are...
Moderna and OpenAI Collaborate To Advance mRNA Medicine
Digital Journal· 1 day agoCAMBRIDGE, MA AND SAN FRANCISCO, CA / ACCESSWIRE / April 24, 2024 / Moderna, Inc. (NASDAQ:MRNA) and OpenAI today announced their ongoing collaboration to co-innovate with ...
U.S. Could Vaccinate a Fifth of Americans in a Bird Flu Emergency
Barrons.com· 5 days agoS. could protect healthcare workers, law enforcement and fire personnel, pregnant...other...
FOCUS-China's drugmakers can't sell mRNA shots but haven't quit yet
Reuters via Yahoo Finance· 6 days agoChina's vaccine developers stuck with unused mRNA COVID shots and idle manufacturing plants are pursuing new targets for the novel messenger ...
At Moderna, OpenAI’s GPTs Are Changing Almost Everything
The Wall Street Journal· 1 day ago“People literally talk about how AI is going to cure diseases someday, and I think this is a very...
Cerity Partners LLC Grows Stock Position in Moderna, Inc. (NASDAQ:MRNA)
ETF DAILY NEWS· 12 hours agoThe firm owned 5,626 shares of the company’s stock after buying an additional 2,903 shares during the quarter. Cerity Partners LLC’s holdings in
Scripps Research reports progress toward creating vaccine against the harmful 'zombie' drug xylazine
U-T San Diego· 7 days agoThe institute’s experimental vaccine blocked xylazine’s toxic effect in experiments conducted on...
Moderna director Noubar Afeyan sells over $1.5 million in stock By Investing.com
Investing.com· 6 days agoThe filings show that Afeyan sold 8,243 shares at an average price of $103.10, 6,475 shares at an...
Moderna stock traded in the red for the eighth straight day (NASDAQ:MRNA)
Seeking Alpha· 6 days agoThe stock closed down 0.58% at $101.41. MRNA has lost about 29.6% in the last 12 months and YTD, the...